Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.019 | 0.7 |